Celularity Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Celularity Inc. (CELU) on June 25, 2026, covering events that occurred on June 19, 2026. The company is a biotechnology firm incorporated in Delaware, with its principal executive offices in Florham Park, New Jersey. The filing is primarily focused on corporate governance changes, specifically the appointment of new officers and a director.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current event disclosure and does not contain financial statements or performance metrics.
Material Changes
The material change reported is the restructuring of the company's executive leadership and Board of Directors effective June 19, 2026:
- Steven N. Gordon, Esq. was appointed as Chief Operating and Administrative Officer and simultaneously appointed as a member of the Board of Directors. He previously served as EVP, Business Affairs since January 2026.
- K. Harold Fletcher, Esq. was appointed as Chief Legal and Strategy Officer and Corporate Secretary. He previously served as EVP, Legal and Strategy since January 2026.
Guidance, Outlook, and Risks
The filing does not contain financial guidance, outlook, or specific risk factors. Management commentary is limited to the professional backgrounds of the newly appointed officers, noting Mr. Gordon's experience in corporate finance and biotechnology, and Mr. Fletcher's expertise in corporate governance and securities law. Compensation arrangements for the new officers will be disclosed in subsequent filings if required.
Key Facts for Investor Verification
- Verify the specific compensation packages for Steven N. Gordon and K. Harold Fletcher in upcoming filings.
- Confirm the impact of these leadership changes on the company's strategic direction and operational execution.
- Review subsequent filings for any related party transactions involving the new director, Mr. Gordon.